{
    "title": "Shire's eye drug data could strengthen bid for Baxalta, says CEO",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-3291759/Shire-resubmit-dry-eye-disease-drug-FDA-new-study-data.html",
    "date": "2015-10-27",
    "keywords": [
        "drug",
        "baxalta",
        "lifitegrast",
        "study",
        "fda",
        "company",
        "approval",
        "eye",
        "bid",
        "october",
        "market",
        "year",
        "ornskov",
        "takeover",
        "shire",
        "percent",
        "condition",
        "share",
        "price",
        "uncertainty",
        "ceo",
        "gmt",
        "email",
        "paul",
        "sandlelondon",
        "tuesday",
        "executive",
        "flemming",
        "news",
        "attempt",
        "leader",
        "diseaseslifitegrast",
        "patient",
        "resubmission",
        "blockbuster",
        "food",
        "administration",
        "disease",
        "month",
        "studyornskov",
        "quarter",
        "package",
        "reutersthe",
        "product",
        "class",
        "submission",
        "europe",
        "canadian",
        "appeal",
        "proposal",
        "drop",
        "interest",
        "august",
        "stock",
        "wider",
        "rout",
        "investor",
        "pressure",
        "equity",
        "story",
        "part",
        "today",
        "data",
        "fifth",
        "total",
        "medicine",
        "likelihood",
        "development",
        "rise",
        "prescription",
        "restasis",
        "efficacy",
        "bar",
        "reporting",
        "ben",
        "hirschler",
        "editing",
        "croft",
        "david",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}